Table 2.
Pre‐COVID‐19 (20 months)a | COVID‐19 pandemic (4 months)a | Post‐COVID‐19 (20 months)a | |
---|---|---|---|
ARTI, n (%) | |||
Total | 133 (0.5) | 2 (0.2) | 12 (0.1) |
RSV + FluA | 85 | 2 | 0 |
RSV + FluB | 42 | 0 | 6 |
FluA + FluB | 3 | 0 | 5 |
AdV + FluB | 2 | 0 | 0 |
AdV + FluA | 1 | 0 | 0 |
RSV + AdV | 0 | 0 | 1 |
AGE, n (%) | |||
RV + enteric AdV | 490 (1.3) | 5 (0.2) | 143 (0.6) |
Abbreviations: AdV, adenoviruses; AGE, acute gastroenteritis; ARTI, acute respiratory tract infections; COVID‐19, coronavirus disease 2019; FluA, influenza A virus; FluB, influenza B virus; RSV, respiratory syncytial virus; RV, rotaviruses.
Pre‐COVID‐19: June 1, 2018 to January 31, 2020; COVID‐19 pandemic: February 1– May 31, 2020 (school closure); and post‐COVID‐19: June 1, 2020 to January 31, 2022.